These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 85367)

  • 41. Assessment of specific anti-tumour immunity in lung cancer patients by means of leukocyte migration inhibition test. The role of antigenic preparations.
    Zeromski J; Jezewska E; Lawniczak M; Górny MK
    Mater Med Pol; 1982; 14(1-2):68-73. PubMed ID: 7186996
    [No Abstract]   [Full Text] [Related]  

  • 42. Inhibition of leucocyte migration by potassium chloride extracts of human tumor cells in ascites and from tissues.
    Imai K; Hosokawa Y; Abe H; Yachi A; Wada T
    Gan; 1977 Oct; 68(5):581-7. PubMed ID: 73489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Idiotypic determinants in alloantigen receptors. I. Role in a leucocyte migration inhibition reaction.
    Braun M; Sztein MB; Satz ML; Jasnis MA; Saal F
    Scand J Immunol; 1979; 10(1):25-30. PubMed ID: 89691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of immune lymphocytes in corneal reaction against foreign tissue antigen, as determined by leucocyte migration inhibition test.
    Basu PK; Carre F
    Can J Ophthalmol; 1974 Apr; 9(2):236-43. PubMed ID: 4837787
    [No Abstract]   [Full Text] [Related]  

  • 45. Circadian rhythms in cell migration in vitro, and its effect on antigen-induced migration inhibition.
    Richens E; Brown KA; Collins AJ; Bacon PA
    Clin Exp Immunol; 1975 Feb; 19(2):343-6. PubMed ID: 1212804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human intracranial glioma.
    Lin SM; Lee CS; Chuang CY; Hung CC
    Taiwan Yi Xue Hui Za Zhi; 1979 Feb; 78(2):111-9. PubMed ID: 286750
    [No Abstract]   [Full Text] [Related]  

  • 47. Experiments for producing specific immunological tolerance by intrauterinely administered immunocompetent human cells.
    Osz E; Réthy L
    Ann Immunol Hung; 1975; 18():181-6. PubMed ID: 68707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leucocyte-migration test in nephrotic syndrome.
    Bendixen G
    Lancet; 1972 Jun; 1(7765):1394. PubMed ID: 4113596
    [No Abstract]   [Full Text] [Related]  

  • 49. A leukocyte adherence inhibition test for cell-mediated immunity.
    Lampert F; Dietmair E
    Klin Wochenschr; 1973 Feb; 51(4):198-9. PubMed ID: 4691178
    [No Abstract]   [Full Text] [Related]  

  • 50. The modifying effect of autologous serum on leukocyte migration inhibition by liver antigens in systemic lupus erythematosus.
    Hughes P; Holt S; Rowell NR
    Br J Dermatol; 1975 Apr; 92(4):401-6. PubMed ID: 1156554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular immunity in chronic ophthalmic disorders. 3. Leukocyte migration inhibition in uveitis.
    Feinberg EB; Shore B; Leopold IH; Henley WL
    Am J Ophthalmol; 1972 Jan; 73(1):68-72. PubMed ID: 5007348
    [No Abstract]   [Full Text] [Related]  

  • 52. Morphologic investigations on the leucocyte migration test (LMT).
    Egeberg J; Bendixen G; Nerup J
    Scand J Immunol; 1972; 1(3):205-16. PubMed ID: 4677129
    [No Abstract]   [Full Text] [Related]  

  • 53. Cellular immunity in mammary cancer patients as measured by the leukocyte migration test (LMT). A follow-up study.
    Rieche K; Arndt A; Pasternak G
    Int J Cancer; 1976 Feb; 17(2):212-8. PubMed ID: 1248905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma.
    Halliday WJ; Maluish AE; Little JH; Davis NC
    Int J Cancer; 1975 Oct; 16(4):645-58. PubMed ID: 51836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of tumor specific immunity in rats using in vitro migration inhibitory tests.
    Kalafut F; Novotná L; Klobusická M; Koníková E
    Neoplasma; 1977; 24(6):573-81. PubMed ID: 74025
    [No Abstract]   [Full Text] [Related]  

  • 56. The mechanism of tumour cell induced inhibition of human leucocyte migration.
    Ross CE; Cochran AJ; Jackson AM; Mackie RM; Ogg LJ
    Eur J Cancer (1965); 1979 Jul; 15(7):995-1000. PubMed ID: 314896
    [No Abstract]   [Full Text] [Related]  

  • 57. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.
    Bubeník J; Baresová M; Viklický V; Jakoubková J; Sainerová H; Donner J
    Int J Cancer; 1973 May; 11(3):765-73. PubMed ID: 4133950
    [No Abstract]   [Full Text] [Related]  

  • 58. Primary culture inhibition test.
    Humphrey LJ; Boehm OR
    Oncology; 1972; 26(5):447-51. PubMed ID: 4649569
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of estrogens on the development of the leukocyte migration inhibition reaction in vitro in malignant neoplasms].
    Alferov AN; Grinevich IuA
    Probl Endokrinol (Mosk); 1979; 25(4):31-4. PubMed ID: 314113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the specificity of the leukocyte migration inhibition test against histologically homologous and heterologous neoplastic antigens in cancer patients.
    Mantovani G; Manca MA; Cossu F; Proto E; Taglieri G; Mirigliani F; Gaspardini G
    Tumori; 1981; 67(3):169-75. PubMed ID: 6169178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.